The Hyaluronic Acid (HA) Quantitative ELISA Assay is a sensitive and reliable method for detecting and measuring HA levels in serum samples, providing valuable insights into various pathological conditions. HA, a key component of the extracellular matrix, plays a crucial role in tissue hydration, repair, and inflammation. Elevated serum HA levels are commonly associated with liver diseases such as fibrosis and cirrhosis, reflecting the extent of hepatic damage. 

Additionally, increased HA concentrations are observed in renal insufficiency, where impaired clearance leads to accumulation. The assay is also instrumental in studying rheumatic diseases like rheumatoid arthritis, where HA reflects joint inflammation and cartilage degradation. In oncology, serum HA serves as a biomarker for certain cancers, including mesothelioma and Wilms’ tumor, aiding in disease monitoring. HA quantification helps evaluate inflammatory and cardiovascular conditions by indicating extracellular matrix remodeling and endothelial dysfunction. Overall, the HA Quantitative ELISA Assay is an essential tool for clinical research and diagnostics, enabling precise monitoring of disease progression and therapeutic efficacy through serum analysis.